About
Biologics, Biosimilars
Areas of Focus
Categories
BiosimilarsBiologics & BiopharmaceuticalBiotech
Clinical Trials (24)
View allTotal Trials
24
As Lead Sponsor
18
As Collaborator
6
Total Enrollment
4,164
By Phase
PHASE2: 8PHASE1/PHASE2: 1PHASE1: 9PHASE4: 1PHASE3: 4
By Status
COMPLETED: 8RECRUITING: 7NOT_YET_RECRUITING: 4TERMINATED: 2ACTIVE_NOT_RECRUITING: 2UNKNOWN: 1
Clinical Trials Pipeline24 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT07214987Collaborator
PDT For Induction Therapy For Head And Neck Cancer
PHASE2Not yet recruiting
26 participants
Started: Mar 9, 2026 · Completed: Sep 1, 2029
NCT05479045Collaborator
A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients
PHASE2Not yet recruiting
24 participants
Started: Jan 31, 2026 · Completed: Nov 30, 2027
NCT07209189Collaborator
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
PHASE2Not yet recruiting
75 participants
Started: Nov 1, 2025 · Completed: Dec 1, 2030
NCT07140679Collaborator
Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
PHASE2Recruiting
40 participants
Started: Sep 19, 2025 · Completed: Dec 31, 2029
NCT06940180Collaborator
Toripalimab With Chemotherapy for Sinus Cancer
PHASE2Recruiting
20 participants
Started: Jun 17, 2025 · Completed: Feb 1, 2029
Locations (1)
Headquarters
Redwood City, CA, United States
Map
Loading map...